Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells

Citation
N. Quirici et al., Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells, BR J HAEM, 115(1), 2001, pp. 186-194
Citations number
60
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BRITISH JOURNAL OF HAEMATOLOGY
ISSN journal
00071048 → ACNP
Volume
115
Issue
1
Year of publication
2001
Pages
186 - 194
Database
ISI
SICI code
0007-1048(200110)115:1<186:DAEOEC>2.0.ZU;2-N
Abstract
We report a method of purifying, characterizing and expanding endothelial c ells (ECs) derived from CD133(+) bone marrow cells, a subset of CD34(+) hae matopoietic progenitors. Isolated using immunomagnetic sorting (mean purity 90 +/-5%), the CD133(+) bone marrow cells were grown on fibronectin-coated flasks in M199 medium supplemented with fetal bovine serum (FBS), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) an d insulin growth factor (IGF-1). The CD133(+) fraction contained 95 +/-4% C D34(+) cells, 3 +/-2% cells expressing VEGF receptor (VEGFR-2/KDR), but did not express von Willebrand factor (VWF), VE-cadherin, P1H12 or TE-7. After 3 weeks of culture, the cells formed a monolayer with a, typical EC morpho logy and expanded 11 +/-5 times. The cells were further purified using Ulex europaeus aggluffnin-1 (URA-1)-fluorescein isothiocyanate (FITC) and anti- FITC microbeads, and expanded with VEGF for a further 3 weeks. All of the c ells were CD45(-) and CD14(-), and expressed several endothelial markers (U RA-1, VWF, P1H12, CD105, E-selectin, VCAM-1 and, VE-cadherin) and typical W eibel-Palade bodies. They had a high proliferative potential (up to a 2400- fold increase in cell number after 3 weeks of culture) and the capacity, to modulate cell surface antigens upon stimulation with inflammatory cytokine s. Purified ECs were also co:cultivated with CD34(+) cells, in parallel wit h a purified fibroblastic cell monolayer. CD34(+) cells (10 x 10(5)) gave r ise to 17951 +/- 2422 CFU-GM colonies when grown on endothelial cells, and to 12 928 +/- 4415 CFU-GM colonies on fibroblast monolayers. The ECs also s upported erythroid blast-forming unit (BFU-E) colonies better. These result s suggest that bone marrow CD133(+) progenitor cells can give, rise to high ly purified ECs, which have a high proliferative capacity, can be activated by inflammatory cytokines and are superior to fibroblasts in supporting ha ematopoiesis. Our data support the hypothesis that endothelial cell progeni tors are present in adult bone marrow and may contribute to neo-angiogenesi s.